Why the study?
Point of care tests can reduce clinical decision time in emergencies, but need verification for correlation and precision compared to clinical laboratory assays.
Does the SelexOn BNP point-of-care assay provide comparable analytical performance to established BNP assays (Centaur and Triage)?
Cross-Sectional (n=220)
Yes
Does the SelexOn BNP point-of-care assay provide comparable analytical performance to established BNP assays (Centaur and Triage)?
Effect estimate: r = 0.930
The SelexOn BNP point-of-care assay shows acceptable correlation with established assays but exhibits a negative systematic bias at clinical decision levels, indicating a need for calibration adjustments.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jekarl et al. (2020) conducted a cross-sectional in Heart failure (n=220). SelexOn BNP assay vs. ADVIA Centaur BNP and Triage BNP assays was evaluated on Correlation with established BNP assays (r = 0.930).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: